Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis

The purpose of the present systematic review is to clarify whether adjuvant chemotherapy improves survival rates in women with stage IC1 ovarian cancer. We searched Medline, Scopus, Clinicaltrials.gov, EMBASE, Cochrane Central Register of Controlled Trials CENTRAL and Google Scholar. We considered c...

Descripción completa

Detalles Bibliográficos
Autores principales: Pergialiotis, Vasilios, Liatsou, Efstathia, Rouvali, Aggeliki, Haidopoulos, Dimitrios, Efthymios, Dimitrios, Liontos, Michalis, Rodolakis, Alexandros, Thomakos, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406671/
https://www.ncbi.nlm.nih.gov/pubmed/36005192
http://dx.doi.org/10.3390/curroncol29080454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406671/
https://www.ncbi.nlm.nih.gov/pubmed/36005192
http://dx.doi.org/10.3390/curroncol29080454

Ejemplares similares